Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-12-13

Clinical Trial Update: REGISTRY OF COMPLETE RESPONSES TO SUNITINIB IN SPANISH PATIENTS WITH METASTATIC RENAL CELL CARCINOMA

View source ↗

Summary

Clinical trial update reporting complete responses to sunitinib in Spanish patients with metastatic renal cell carcinoma; results posted from a completed study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sunitinib (sunitinib)

Snippet

Sponsor: Pfizer | Conditions: Carcinoma, Renal Cell | Status: COMPLETED | Results posted: 2021-12-13